Prasun Chakraborty
Founder, Innovator & Chief Executive Officer Genevation
Prasun Chakraborty is an innovator, entrepreneur, and cancer vaccine pioneer with over 18 years of experience in IVT technology, oncology, and RNA biology. His scientific work has significantly advanced the understanding of transcription and splicing in cancer, particularly in pediatric oncology. As a scientist, speaker, and reviewer, Prasun has shared his expertise at leading international conferences, contributing to global conversations on cutting-edge cancer research.
Having worked across both academia and industry, Prasun is now focused on translating scientific breakthroughs into transformative therapies. He is leading the development of a groundbreaking cancer vaccine, combining his deep expertise in molecular biology with a commitment to bold, high-impact innovation.
Prasun’s key areas of expertise include IVT technology, RNA biology, oncology, transcription and splicing in cancer, biotech innovation, and fundraising. Through collaborations with investors, scientists, and visionary partners, he aims to push the boundaries of cancer treatment and bring life-changing therapies to patients worldwide.
Seminars
- Accelerating Neoantigen Discovery – How AI integrates genomic, transcriptomic, and immunological data to rapidly identify and prioritize tumor-specific targets
- Optimizing Vaccine Design – Using predictive models and adaptive strategies to anticipate immune response and iteratively refine personalized formulations
- Translating Innovation into Impact – Case studies where AI platforms have shortened development timelines, improved patient outcomes, and opened new horizons for immunotherapy
